Answers are grounded in this paper and cite their sources.
In recent years, N,N’ -diarylureas have emerged as a promising chemotype for the treatment of schistosomiasis, a parasite-caused disease that poses a considerable health burden to millions of people worldwide. Here, we report a novel series of N,N’ -diarylureas featuring the scarcely explored pentafluorosulfanyl group (SF 5 ).
No takes yet. Share an insight, caveat, or question.
Probst et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: